Catalyst Pharmaceuticals (CPRX) Cash & Current Investments (2010 - 2026)
Catalyst Pharmaceuticals posted quarterly Cash & Current Investments of $755.9 million for Q1 2026, up 30.17% year-on-year from $580.7 million in Q1 2025, and up 6.58% on a QoQ basis from $709.2 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 17 years of Cash & Current Investments data on file, last reported at $755.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 30.17% year-over-year to $755.9 million; the trailing twelve-month figure through Mar 2026 stood at $755.9 million (up 30.17% YoY), and the FY2025 full-year result was $709.2 million, up 37.02% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $755.9 million, up from $709.2 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $755.9 million in Q1 2026 and bottomed at $121.0 million in Q3 2023.
- The 5-year median for Cash & Current Investments is $310.4 million (2024), against an average of $387.8 million.
- The widest annual swing landed in 2023, when Cash & Current Investments tumbled 53.87%; it then jumped 276.03% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $298.4 million in 2022, then sank by 53.87% to $137.6 million in 2023, then surged by 276.03% to $517.6 million in 2024, then soared by 37.02% to $709.2 million in 2025, then rose by 6.58% to $755.9 million in 2026.
- The last three Cash & Current Investments figures came in at $755.9 million (Q1 2026), $709.2 million (Q4 2025), and $689.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 755.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 755.86 Mn |
| Dec 31, 2025 | 709.17 Mn |
| Sep 30, 2025 | 689.89 Mn |
| Jun 30, 2025 | 652.80 Mn |
| Mar 31, 2025 | 580.66 Mn |
| Dec 31, 2024 | 517.55 Mn |
| Sep 30, 2024 | 442.33 Mn |
| Jun 30, 2024 | 375.69 Mn |
| Mar 31, 2024 | 310.41 Mn |
| Dec 31, 2023 | 137.64 Mn |
| Sep 30, 2023 | 120.97 Mn |
| Jun 30, 2023 | 178.79 Mn |
| Mar 31, 2023 | 148.25 Mn |
| Dec 31, 2022 | 298.40 Mn |
| Sep 30, 2022 | 256.07 Mn |
| Jun 30, 2022 | 220.79 Mn |
| Mar 31, 2022 | 197.80 Mn |
| Dec 31, 2021 | 191.27 Mn |
| Sep 30, 2021 | 174.79 Mn |
| Jun 30, 2021 | 155.28 Mn |
| Mar 31, 2021 | 143.30 Mn |
| Dec 31, 2020 | 140.28 Mn |
| Sep 30, 2020 | 127.11 Mn |
| Jun 30, 2020 | 115.05 Mn |
| Mar 31, 2020 | 101.75 Mn |
| Dec 31, 2019 | 94.52 Mn |
| Sep 30, 2019 | 76.54 Mn |
| Jun 30, 2019 | 59.92 Mn |
| Mar 31, 2019 | 45.63 Mn |
| Dec 31, 2018 | 53.48 Mn |
| Sep 30, 2018 | 61.66 Mn |
| Jun 30, 2018 | 68.41 Mn |
| Mar 31, 2018 | 77.94 Mn |
| Dec 31, 2017 | 84.01 Mn |
| Sep 30, 2017 | 33.91 Mn |
| Jun 30, 2017 | 35.13 Mn |
| Mar 31, 2017 | 36.53 Mn |
| Dec 31, 2016 | 40.41 Mn |
| Sep 30, 2016 | 18.21 Mn |
| Jun 30, 2016 | 45.25 Mn |
| Mar 31, 2016 | 25.95 Mn |
| Dec 31, 2015 | 31.95 Mn |
| Sep 30, 2015 | 36.47 Mn |
| Jun 30, 2015 | 40.94 Mn |
| Mar 31, 2015 | 45.04 Mn |
| Dec 31, 2014 | 35.56 Mn |
| Sep 30, 2014 | 37.73 Mn |
| Jun 30, 2014 | 18.52 Mn |
| Mar 31, 2014 | 4.79 Mn |
| Dec 31, 2013 | 19.70 Mn |
| Sep 30, 2013 | 23.64 Mn |
| Jun 30, 2013 | 7.36 Mn |
| Mar 31, 2013 | 646,045.00 |
| Dec 31, 2012 | 8.91 Mn |
| Sep 30, 2012 | 11.97 Mn |
| Jun 30, 2012 | 7.51 Mn |
| Mar 31, 2012 | 4.72 Mn |
| Dec 31, 2011 | 6.03 Mn |
| Sep 30, 2011 | 4.16 Mn |
| Jun 30, 2011 | 5.41 Mn |
| Mar 31, 2011 | 6.87 Mn |
| Dec 31, 2010 | 5.48 Mn |
| Sep 30, 2010 | 6.25 Mn |